Research conducted at Wayne State University and the Karmanos Cancer Institute illuminated the need for bioinformatics software as a missing component for effective cancer research. The Seller developed next-generation algorithms and tools that significantly improved researchers’ ability to interpret experimental data. These were initially offered for free through a university laboratory website, where they gained rapid adoption.

Recognizing the broader demand and the need for sustainable growth, the company transitioned into a commercial enterprise with the support of grants, including a $150,000 SBIR prototype. Through the years, the Company developed multiple trademarks and patents.

Today, the software bridges the critical gap between the massive data generated by modern laboratory equipment and actionable biological insights with specialized cloud-based software solutions to create high-throughput biological data analysis. The company’s software transforms terabytes of raw data into meaningful knowledge for life sciences and medical research.

NDA is required to secure the comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.